The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.46
Bid: 42.46
Ask: 42.52
Change: -0.22 (-0.52%)
Spread: 0.06 (0.141%)
Open: 42.86
High: 42.86
Low: 42.10
Prev. Close: 42.68
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of 100th development

29 Jun 2023 07:00

RNS Number : 3005E
Assura PLC
29 June 2023
 

29 June 2023

Assura plc

 

Completion of 100th development

 

Assura plc ("Assura"), the leading primary care property investor and developer, today announces the practical completion of its 100th development - Prestbury Medical Centre in Wolverhampton - as it marks two decades of developing healthcare infrastructure in the UK.

 

Jonathan Murphy, CEO, said:

"We are proud to have supported the delivery of health care for two decades, creating high-quality premises that serve the needs of health professionals and patients in a primary care setting and generating value for shareholders.

"The new Prestbury Medical Centre in Wolverhampton will provide an essential new home for two relocating GP practices, serving a growing patient list of over 14,500 people and allow additional health services to be moved out of hospital into a community setting. We are pleased to have again worked with Medcentres to deliver this much-needed community facility and that our funding approach has allowed further sustainability enhancements to be made for the benefit of the GPs, health professionals and patients that will use the building.

"As the leading developer in our sector, we have now completed 100 buildings over the course of our 20-year history - delivering modern, fit-for-purpose facilities which are vital for the long-term delivery of community health services that ease the pressures currently being faced by the NHS."

Prestbury Medical Centre, Wolverhampton

 

The £6 million forward-funded scheme accommodates the health needs of a growing local population, providing state-of-the-art, modern premises for over 14,500 patients. It sees two local surgeries relocating from previous premises that were not fit for purpose and, alongside facilitating critical GP services, will allow the provision of additional training capacity, a greater range of community and out-of-hospital services as well as incorporating a telehealth hub to support digital health care delivery.

 

In line with Assura's sustainability strategy, the building has been designed to achieve BREEAM "Excellent" certification ("Outstanding" for energy efficiency) and an EPC rating of "A". These ratings have been achieved through delivering an energy solution incorporating air source heat pumps, EV charging points and use of natural ventilation, as well as 70 m2 of photo-voltaic ("PV") panels.

 

Interiors also reflect the "Designing for Everyone" toolkit launched by Assura in 2022, which seeks to support GP practices in improving their build environments for people with disabilities and conditions such as dementia, neurodiversity and anxiety.

 

The building, developed under a forward-funding agreement with Medcentres PLC, is 100% let to the GPs on a 25-year lease with open market rent reviews every three years and is a priority project for the NHS Black Country Integrated Care Board.

 

- ENDS -

 

 

 

 

 

Assura plc David Purcell, Investor Relations Director

Tel: 01925 945354 Email: Investor@assura.co.uk

 

FGS Global

Gordon SimpsonJames Thompson

 

Tel: 0207 251 3801 Email: Assura@fgsglobal.com

 

 

Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Warrington, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served.

 

A constituent of the FTSE 250 and the EPRA* indices, as at 31 March 2023, Assura's portfolio was valued at £2.7 billion.

 

At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026. 

 

Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUWSWROWUNUAR
Date   Source Headline
27th Jun 20234:18 pmRNSHolding(s) in Company
27th Jun 20238:33 amRNSHolding(s) in Company
15th Jun 20237:31 amRNSScrip Calculation Price
14th Jun 20239:01 amRNSHolding(s) in Company
12th Jun 20234:23 pmRNSDirector/PDMR Shareholding
5th Jun 202310:54 amRNSDirector/PDMR Shareholding
2nd Jun 20237:00 amRNSAnnual Report & Notice of AGM
1st Jun 20237:00 amRNSNotice of Dividend
23rd May 20237:00 amRNSAssura Full Year Results 2023
12th May 20237:00 amRNSNotice of Results
10th May 202310:53 amRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSTotal Voting Rights
25th Apr 20234:12 pmRNSHolding(s) in Company
17th Apr 20234:06 pmRNSDirector/PDMR Shareholding
11th Apr 20238:43 amRNSDirector/PDMR Shareholding
11th Apr 20237:00 amRNSScrip Dividend Declaration
16th Mar 202310:13 amRNSScrip Calculation Price
13th Mar 20237:00 amRNSMSCI ESG rating upgrade and energy reduction pilot
7th Mar 202310:43 amRNSDirector/PDMR Shareholding
2nd Mar 20237:00 amRNSNotice of Dividend
15th Feb 20231:51 pmRNSHolding(s) in Company
7th Feb 20239:57 amRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSTotal Voting Rights
26th Jan 20231:48 pmRNSHolding(s) in Company
16th Jan 20237:00 amRNSTrading Update
13th Jan 20232:55 pmRNSDirector/PDMR Shareholding
9th Jan 202311:33 amRNSDirector/PDMR Shareholding
9th Jan 20237:00 amRNSScrip Dividend Declaration
15th Dec 20229:07 amRNSScrip calculation price
6th Dec 20229:03 amRNSDirector/PDMR Shareholding
1st Dec 20227:00 amRNSDividend Declaration
22nd Nov 20227:00 amRNSDelivering continued growth
15th Nov 202212:15 pmRNSHolding(s) in Company
8th Nov 20229:02 amRNSDirector/PDMR Shareholding
1st Nov 20222:02 pmRNSHolding(s) in Company
31st Oct 20228:43 amRNSTotal Voting Rights
17th Oct 202212:10 pmRNSDirector/PDMR Shareholding
11th Oct 20221:49 pmRNSHolding(s) in Company
10th Oct 20227:00 amRNSScrip Dividend Declaration
7th Oct 202210:14 amRNSDirector/PDMR Shareholding
5th Oct 20227:00 amRNSTrading Update
15th Sep 20227:00 amRNSScrip calculation price
14th Sep 20225:37 pmRNSDirector/PDMR Shareholding
13th Sep 20224:28 pmRNSHolding(s) in Company
1st Sep 20227:00 amRNSDividend Declaration
8th Aug 202212:51 pmRNSDirector/PDMR Shareholding
29th Jul 20229:27 amRNSTotal Voting Rights
18th Jul 20222:53 pmRNSDirector/PDMR Shareholding
13th Jul 20225:17 pmRNSExercise of Nil Cost Options under PSP
13th Jul 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.